Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Capodanno
Stephan Windecker

Showing results (401-410 of 2,160) with videos related to

Pageof 216
Sort By:
The New England Journal of Medicine|July 9, 2020
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. ReplyGeorge D Dangas, Ole De Backer, Stephan Windecker
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 11, 2017
Surgical antegrade transcatheter mitral valve implantation for symptomatic mitral valve disease and heavily calcified annulusBettina Langhammer, Christoph Huber, Stephan Windecker, et al.
JACC. Cardiovascular Interventions|September 24, 2021
Learning From Failure at the CUTTING-EDGE of Transcatheter Mitral Valve TherapiesAlessandro Sticchi, Fabien Praz, David Reineke, et al.
Lancet (London, England)|May 16, 2019
Biodegradable-polymer stents versus durable-polymer stents - Authors' replyPeter Jüni, Dik Heg, Stephan Windecker, et al.
European Heart Journal. Case Reports|October 30, 2019
Case report of simultaneous transcatheter mitral valve-in-valve implantation and percutaneous closure of two paravalvular leaksMasahiko Asami, Thomas Pilgrim, Stephan Windecker, et al.
Expert Review of Cardiovascular Therapy|June 15, 2019
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an updateAntonio Greco, Piera Capranzano, Marco Barbanti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery diseaseStéphane Cook, Holger Nef, Davide Capodanno, et al.
International Journal of Cardiology|June 26, 2012
Increasing CHADS₂ scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleedingDavide Capodanno, Piera Capranzano, Giuseppe Giacchi, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 8, 2020
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequenceAndrea Rubboli, Marco Valgimigli, Davide Capodanno, et al.
Pageof 216

Showing results (401-410 of 2,160) with videos related to

Sort By:
Pageof 216
The New England Journal of Medicine|July 9, 2020
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. ReplyGeorge D Dangas, Ole De Backer, Stephan Windecker
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 11, 2017
Surgical antegrade transcatheter mitral valve implantation for symptomatic mitral valve disease and heavily calcified annulusBettina Langhammer, Christoph Huber, Stephan Windecker, et al.
JACC. Cardiovascular Interventions|September 24, 2021
Learning From Failure at the CUTTING-EDGE of Transcatheter Mitral Valve TherapiesAlessandro Sticchi, Fabien Praz, David Reineke, et al.
Lancet (London, England)|May 16, 2019
Biodegradable-polymer stents versus durable-polymer stents - Authors' replyPeter Jüni, Dik Heg, Stephan Windecker, et al.
European Heart Journal. Case Reports|October 30, 2019
Case report of simultaneous transcatheter mitral valve-in-valve implantation and percutaneous closure of two paravalvular leaksMasahiko Asami, Thomas Pilgrim, Stephan Windecker, et al.
Expert Review of Cardiovascular Therapy|June 15, 2019
Antithrombotic pharmacotherapy after transcatheter aortic valve implantation: an updateAntonio Greco, Piera Capranzano, Marco Barbanti, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 21, 2016
Will ABSORB III change my practice? Everolimus-eluting bioresorbable scaffolds for coronary artery diseaseStéphane Cook, Holger Nef, Davide Capodanno, et al.
International Journal of Cardiology|June 26, 2012
Increasing CHADS₂ scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleedingDavide Capodanno, Piera Capranzano, Giuseppe Giacchi, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
P2Y12 Inhibitor Monotherapy: Considerations for Acute and Long-Term Secondary Prevention Post-PCIAntonio Greco, Maria Sara Mauro, Davide Capodanno, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 8, 2020
Choices in antithrombotic management for patients with atrial fibrillation undergoing percutaneous coronary intervention: questions (and answers) in chronological sequenceAndrea Rubboli, Marco Valgimigli, Davide Capodanno, et al.
Pageof 216